A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)

Clinical trial NCT06137183 · TERMINATED

Trial details

NCT number: NCT06137183
Sponsor: Genentech, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2024-05-01
Primary completion: 2025-06-16
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.